Navigation Links
Novel Investigational Drug May Help American Women Suffering from Breast Pain

A clinical trial for a much needed treatment option for pain associated with fibrocystic breast disease, is in progress nationwide. The severely debilitating symptoms such as breast pain, affects about 26 million women in the United States alone but is often left untreated leaving women feeling hopeless.

As many as 50% of American women talk to their physician about breast pain including swelling, tenderness and lumps that increase prior and during menstruation and may continue for several days. The pain is not only physical. Psychological stress is often associated with undergoing mammograms, ultrasound scans and breast biopsies, techniques frequently utilized by physicians to rule out other diseases of the breast.

"Breast pain associated with fibrocystic breast disease can be physically impairing, leaving women unable to cope with basic daily functions, yet 85% of women don't receive treatment," said Gerianne Tringali DiPiano, President and CEO of FemmePharma Global Healthcare, the company sponsoring the study. "We hope news of this trial will compel women with breast pain associated with fibrocystic breast disease who have been previously diagnosed to seek a study center in their area."

Physicians at centers nationwide will enroll women who have breast pain associated with fibrocystic breast disease.

"The trial allows us to assess a new dosage form of an active pharmaceutical ingredient with a demonstrated safety and efficacy profile. We expect that the new dosage forms will provide a new treatment option for this very important disease state," added Bruce J. Levine MD, FACOG, and investigator of the trial.

About Breast Pain

Breast pain can impair a woman's ability to work, participate in her daily activities, embrace a child or have an intimate relationship with her partner. In addition, breast pain frequently causes increased anxiety and stress in a woman's life as a res ult of dealing with pain each month.

Approximately 15% of women who experience breast pain require prescription medication. Currently there is only one FDA approved prescription medication for pain associated with fibrocystic breast disease. However, this medication typically produces unwanted systemic side effects, which often causes women to stop their necessary treatment. In many cases, women are sent home and told to ice their breasts or purchase a tighter fitting brassiere leaving them feeling hopeless.


'"/>




Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel way to fight cancer
6. Novel test for bowel cancer
7. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
8. Novel Therapy for Chronic Problem
9. Blood Sugar Kept In Control By Novel Protein
10. Novel antibiotic dressing developed for improved wound healing
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/20/2017)... ... ... At Creekwood Dental Arts, Drs. Donna G. Miller and Michelle Hinds are ... in Waco, TX, using the latest dental technology for digital imagery and bite ... details in the oral cavity for accurate diagnoses and customized care plans. These tools ...
(Date:7/20/2017)... ... July 19, 2017 , ... A July 7th ... to, or worsen, varicose veins in some patients, according to medical experts. Washington ... not-so-good practices, like excessive sitting or standing, or regularly nicking yourself while shaving ...
(Date:7/18/2017)... , ... July 18, 2017 , ... ... , What Strategic Decisions Do You Need to Consider?, **An FDAnews Webinar**, Aug. ... , 42 CFR Part 11, “Final Rule for Clinical Trials Registration and Results ...
(Date:7/18/2017)... ... July 18, 2017 , ... Heritage Woods of Benton, a Gardant ... 12:30 p.m. on Aug. 15. , The community, which is located at 1305 Bailey ... who need some help to maintain their independence. , The lunch menu will include ...
(Date:7/17/2017)... ... July 17, 2017 , ... McGraw Family Pledges $3 Million for New Learning ... of Healthcare Clinicians , NORWALK, Connecticut – July 17, 2017 – The McGraw ... in community health by pledging up to $3 million in a challenge gift to ...
Breaking Medicine News(10 mins):
(Date:6/30/2017)... , June 30, 2017 In vitro diagnostics ... start of May, at least ten diagnostic companies have ... investments, public offerings and a loan facility.  The size ... almost $80 million.  Kalorama Information provides a monthly ... Diagnostics Knowledge Center. ...
(Date:6/30/2017)... -- Axium Pharmaceuticals Inc. is a pharmaceutical company aimed at utilizing drug ... forms of existing biologically active molecule. ... Subveta oral spray ... formula, which is designed to prevent precipitation of the active ... provide fast onset of action and is designed to optimize ...
(Date:6/27/2017)... 2017   NuEyes (NuEyes Technologies Inc.) today announced ... its growth in helping the legally blind live more independent ... the leading developer of augmented, virtual and mixed reality smartglasses ... The undisclosed funding amount was provided by strategic partners as ... offices in Abu Dhabi , ...
Breaking Medicine Technology: